Laborchemisch pathologische Schilddrüsenparameter bei Patienten ohne Schilddrüsenerkrankung

Zusammenfassung

Medikamente, Umweltfaktoren, Lebensweise und Krankheiten können die Laborwerte der Schilddrüse verändern. Dabei kann laborchemisch scheinbar sowohl eine Hypothyreose als auch eine Hyperthyreose vorliegen. Fehlende Erfahrung/Kenntnis der pathophysiologischen Zusammenhänge können zu therapeutischen Maßnahmen führen, die entweder unnötig oder manchmal sogar schädlich sind. Diese laborchemischen Veränderungen werden nicht durch Erkrankungen der Schilddrüse hervorgerufen, sondern stellen eher einen Schutzmechanismus für den belasteten bzw. kranken Organismus dar. Veränderungen im Schilddrüsenregelkreis sollen hier durch gebremste metabolische Reaktionen mit vermindertem Energie- und Sauerstoffverbrauch den Organismus schonen.

In dieser Übersicht wird ein Überblick über verschiedene Faktoren gegeben, die bei gesunder Schilddrüse, laborchemisch eine Fehlfunktion vortäuschen können.

Abstract

Medication, environmental influences, lifestyle and illness can alter blood values of the thyroid. In this process biochemically a hypothyroidism as well as hyperthyroidism may occur.

Lack of experience or knowledge of the patho-physiological context may lead to treatments, which are either unnecessary or sometimes even harmful.

Subnormal blood sample results may not be caused by a thyroid disease, but rather constitute a protective mechanism for the stressed or ill organism. Alterations in the thyroid regulation axis may be a protective response to slow down metabolic reactions and reduce energy and oxygen consumption.

In this review an overview of various factors, which may fake a biochemical hormonal disorder for patients with healthy thyroid, will be described.

Schlüsselwörter

NTIS - Non-thyroidal illness syndrome - Low-T3-Syndrom - Schilddrüsenfunktion

Key words

NTIS - non-thyroidal illness syndrome - Low-T3 syndrome - thyroid function

• Literatur

• 1 Boyden TW, Pamenter RW, Stanforth P et al. Evidence for mild thyroidal impairment in women undergoing endurance training. J Clin Endocrinol Metab 1982; 54: 53-56
• 2 Brambilla F, Santonastaso P, Caregaro L et al. Disorders of eating behavior: correlation between hypothalamo-pituitary-thyroid function and psychopathological aspects. Psychoneuroendocrinology 2006; 31: 131-136
• 3 Chopra IJ. Clinical review 86: Euthyroid sick syndrome: is it a misnomer?. J Clin Endocrinol Metab 1997; 82: 329-334
• 4 DeGroot LJ. The Non-Thyroidal Illness Syndrome. In: De Groot LJ, Beck-Peccoz P, Chrousos G. et al. editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000. -2015
• 5 de Vries EM, Fliers E, Boelen A. The molecular basis of the non-thyroidal illness syndrome. J Endocrinol 2015; 225: R67-R81
• 6 Dietrich JW, Brisseau K, Boehm BO. Absorption, transport and bio-availability of iodothyronines. Dtsch Med Wochenschr 2008; 133: 1644-1648
• 7 Dietrich JW, Landgrafe G, Fotiadou EH. TSH and Thyrotropic Agonists: Key Actors in Thyroid Homeostasis. J Thyroid Res 2012; 2012: 351864
• 8 Ehrenkranz J, Bach PR, Snow GL et al. Circadian and Circannual Rhythms in Thyroid Hormones: Determining the TSH and Free T4 Reference Intervals Based Upon Time of Day, Age, and Sex. Thyroid 2015; 25: 954-961
• 9 Eskes SA, Wiersinga WM. Amiodarone and thyroid. Best Pract Res Clin Endocrinol Metab 2009; 23: 735-751
• 10 Fournier JP, Yin H, Yu OH et al. Metformin and low levels of thyroid-stimulating hormone in patients with type 2 diabetes mellitus. CMAJ 2014; 186: 1138-1145
• 11 Glinoer D. What happens to the normal thyroid during pregnancy?. Thyroid 1999; 9: 631-635
• 12 Haugen BR. Drugs that suppress TSH or cause central hypothyroidism. Best Pract Res Clin Endocrinol Metab 2009; 23: 793-800
• 13 Iervasi G, Clerico A, Manfredi C et al. Acute effects of intravenous amiodarone on sulphate metabolites of thyroid hormones in arrhythmic patients. Clin Endocrinol 1997; 47: 699-705
• 14 Kaltenbach TE, Graeter T, Oeztuerk S et al. Thyroid dysfunction and hepatic steatosis in overweight children and adolescents. Pediatr Obes 2016; [Epub ahead of print]
• 15 Khatiwada S, Rajendra KC, Gautam S et al. Thyroid dysfunction and dyslipidemia in chronic kidney disease patients. BMC Endocr Disord 2015; 15: 65
• 16 Köhrle J. Thyroid hormone transporters in health and disease: advances in thyroid hormone deiodination. Best Pract Res Clin Endocrinol Metab 2007; 21: 173-191
• 17 Lahner E, Virili C, Santaguida MG et al. Helicobacter pylori infection and drugs malabsorption. World J Gastroenterol 2014; 20: 10331-10337
• 18 Lechan RM. The dilemma of the nonthyroidal illness syndrome. Acta Biomed 2008; 79: 165-171
• 19 Leung AM, Avram AM, Brenner AV et al. Potential risks of excess iodine ingestion and exposure: statement by the american thyroid association public health committee. Thyroid 2015; 25: 145-146
• 20 Misra M, Klibanski A. Neuroendocrine consequences of anorexia nervosa in adolescents. Endocr Dev 2010; 17: 197-214
• 21 Pappa T, Johannesen J, Scherberg N et al. A TSHβ Variant with Impaired Immunoreactivity but Intact Biological Activity and Its Clinical Implications. Thyroid 2015; 25: 869-876
• 22 Pearce EN, Braverman LE. Environmental pollutants and the thyroid. Best Pract Res Clin Endocrinol Metab 2009; 23: 801-813
• 23 Persani L, Terzolo M, Asteria C et al. Circadian variations of thyrotropin bioactivity in normal subjects and patients with primary hypothyroidism. J Clin Endocrinol Metab 1995; 80: 2722-2728
• 24 Portnay GI, O’Brien JT, Bush J et al. The effect of starvation on the concentration and binding of thyroxine and triiodothyronine in serum and on the response to TRH. J Clin Endocrinol Metab 1974; 39: 191-194
• 25 Premachandra BN, Kabir MA, Williams IK. Low T3 syndrome in psychiatric depression. J Endocrinol Invest 2006; 29: 568-572
• 26 Reinehr T. Obesity and thyroid function. Mol Cell Endocrinol. 2010; 316: 165-171
• 27 Reinhardt W, Mann K. “Non-thyroid illness” or changed thyroid hormone parameter syndrome with non-thyroid illnesses. Med Klin 1998; 93: 662-668
• 28 Rothenbuchner G, Loos U, Kiessling WR et al. The influence of total starvation on the pituitary-thyroid-axis in obese individuals. Acta Endocrinol Suppl 1973; 173: 144
• 29 Sabeen S, Chou C, Holroyd S. Abnormal thyroid stimulating hormone (TSH) in psychiatric long-term care patients. Arch Gerontol Geriatr 2010; 51: 6-8
• 30 Spaulding SW. „No Detectable TSH“ Doesn’t Always Mean a Patient Has Hyperthyroidism or Central Hypothyroidism. Clin Thyroidol 2015; 27: 269-271
• 31 Spaulding SW. Some Elderly Patients with Subclinical Hypothyroidism Apparently Do Not Need Treatment. Clin Thyroidol 2015; 27: 209-211
• 32 Stockigt JR. Guidelines for diagnosis and monitoring of thyroid disease: nonthyroidal illness. Clin Chem 1996; 42: 188-192
• 33 Stockigt JR, Lim CF. Medications that distort in vitro tests of thyroid function, with particular reference to estimates of serum free thyroxine. Best Pract Res Clin Endocrinol Metab 2009; 23: 753-767
• 34 Van den Berghe G. Non-thyroidal illness in the ICU: a syndrome with different faces. Thyroid 2014; 24: 1456-1465 Epub 2014 Jun 19
• 35 Vassart GS, Costagliola S. The thyrotropin receptor. in Werner and Ingbar’s the Thyroid. Bravermanand LE, Uller RP. (Eds.). Lippincott Williams & Wilkins; Philadelphia, Pa, USA: 2005: 176-183
• 36 Voigt K, Gerlach K, Riemenschneider H et al. Sprechstundenprävalenz von Schilddrüsenerkrankungen in der Allgemeinarztpraxis: Ergebnisse der SESAM-4. Z Allg Med 2011; 87: 208-215
• 37 Warner MH, Beckett GJ. Mechanisms behind the non-thyroidal illness syndrome: an update. J Endocrinol 2010; 205: 1-13